Fact CheckerSign in

NCT06172777Completed

A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD

Source: ClinicalTrials.gov · Last updated 24 Jul 2025

Brief summary (registry, in English)

The study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD, it is a multi-centre clinical study. sponsor by Astrazeneca Investment(China) Co.,LTD.

Status (registry)
Completed
Study type
Observational
Enrollment
801 (actual)
First submitted
7 Dec 2023
Start date
8 Feb 2024
Primary completion date
30 Aug 2024
Lead sponsor
AstraZeneca
Diseases
Asthma
NCT number
NCT06172777

What you commit to

  • Study type: Observational
  • Participants enrolled: 801
  • From 8 Feb 2024 to the primary completion date, 30 Aug 2024
  • 41 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any diseases that influence lung function result such as lung cancer, pneumonia, active pulmonary tuberculosis, pulmonary embolism and interstitial lung disease, etc; history of recent surgery that affect lung function results, including thoracotomy surgery, pneumothorax surgery, thoracic drainage, etc
  • Contraindication to spirometry or oscillometry test, or allergic to bronchodilator.

Other

  • Participants are excluded from the study if any of the following criteria apply:
  • Currently pregnant or breast-feeding women
  • Judge by the investigator if the participant is unlikely to comply with study procedures, restrictions, and requirements, will not be enrolled .

Who the study is looking for

  • Participants are eligible to be included in the study only if all of the following criteria apply and signed informed content :
  • Suspected and confirmed asthma
  • Participant must be≥18 years old.
  • Present symptom such as wheezing, cough, chest tightness, shortness of breath, but not confirmed-asthma (without evidence of variable airflow restriction) or confirmed-asthma with evidence of variable airflow restriction (such as positive bronchodilation test, positive bronchial challenge test, variability \>10% in twice daily PEF over 2 weeks, et al) Suspected and confirmed COPD
    • 1 Participant must be ≥40 years old. 2 Present symptom such as chronic cough, sputum production, dyspnoea, but not confirmed-COPD (without evidence of persistent airflow restriction) or confirmed- COPD with evidence of persistent airflow restriction (post-bronchodilator FEV1/FVC\<0.7)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (41)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
BeijingChinaUnknown status
-
Coordinator of this site? Confirm its status
ChangshaChinaUnknown status
-
Coordinator of this site? Confirm its status
ChengduChinaUnknown status
-
Coordinator of this site? Confirm its status
ChongqingChinaUnknown status
-
Coordinator of this site? Confirm its status
DalianChinaUnknown status
-
Coordinator of this site? Confirm its status
FengchengChinaUnknown status
-
Coordinator of this site? Confirm its status
FuyangChinaUnknown status
-
Coordinator of this site? Confirm its status
FuzhouChinaUnknown status
-
Coordinator of this site? Confirm its status
GuangzhouChinaUnknown status
-
Coordinator of this site? Confirm its status
GuiyangChinaUnknown status
-
Coordinator of this site? Confirm its status
HaikouChinaUnknown status
-
Coordinator of this site? Confirm its status
HanchuanChinaUnknown status
-
Coordinator of this site? Confirm its status
HangzhouChinaUnknown status
-
Coordinator of this site? Confirm its status
HaozhouChinaUnknown status
-
Coordinator of this site? Confirm its status
HenanChinaUnknown status
-
Coordinator of this site? Confirm its status
Hong KongChinaUnknown status
-
Coordinator of this site? Confirm its status
JinanChinaUnknown status
-
Coordinator of this site? Confirm its status
JingzhouChinaUnknown status
-
Coordinator of this site? Confirm its status
KunmingChinaUnknown status
-
Coordinator of this site? Confirm its status
MianyangChinaUnknown status
-
Coordinator of this site? Confirm its status
NanchangChinaUnknown status
-
Coordinator of this site? Confirm its status
NantongChinaUnknown status
-
Coordinator of this site? Confirm its status
NingboChinaUnknown status
-
Coordinator of this site? Confirm its status
OrdosChinaUnknown status
-
Coordinator of this site? Confirm its status
PanzhouChinaUnknown status
-
Coordinator of this site? Confirm its status
QionghaiChinaUnknown status
-
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status
-
Coordinator of this site? Confirm its status
ShenyangChinaUnknown status
-
Coordinator of this site? Confirm its status
ShenzhenChinaUnknown status
-
Coordinator of this site? Confirm its status
SuiningChinaUnknown status
-
Coordinator of this site? Confirm its status
SuzhouChinaUnknown status
-
Coordinator of this site? Confirm its status
TaiyuanChinaUnknown status
-
Coordinator of this site? Confirm its status
TaizhouChinaUnknown status
-
Coordinator of this site? Confirm its status
TianjinChinaUnknown status
-
Coordinator of this site? Confirm its status
XinyangChinaUnknown status
-
Coordinator of this site? Confirm its status
YulinChinaUnknown status
-
Coordinator of this site? Confirm its status
YunnanChinaUnknown status
-
Coordinator of this site? Confirm its status
ZhaotongChinaUnknown status
-
Coordinator of this site? Confirm its status
ZhengzhouChinaUnknown status
-
Coordinator of this site? Confirm its status
ZhujiChinaUnknown status
-
Coordinator of this site? Confirm its status
ZigongChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.